Purchase Order 75N92023P00216
Award Date 9/29/23
Potential Completion Date 9/28/24
Potential Value $26K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), awarded a firm fixed-price purchase order to Illumina, Inc. to provide service and support for the agency's NextSeq 2000 DNA sequencing instruments. The $25,959 contract has a completion date of September 28, 2025 and does not have a set-aside designation. Illumina is a manufacturer of genomic analysis instruments and reagents, and has previously supported sequencing needs across various...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $94,792 firm fixed price delivery order to Illumina, Inc. of Bethesda, Maryland. The delivery order was issued under an existing indefinite delivery contract with the manufacturer to supply various sequencing systems, reagents, and services in support of genomic research. As the sole provider of the sequencing platforms used at the agency, Illumina will deliver proprietary...
- This is a firm fixed-price purchase order contract awarded to Illumina, Inc., a biotechnology company specializing in genetic sequencing and genomic analysis technologies, by the National Human Genome Research Institute (NHGRI), a civilian agency under the National Institutes of Health (NIH). The $25,959 contract is for the provision of NEXTSEQ2000 sequencing services and has an ultimate completion date of September 28, 2026. The contract was awarded on September 29, 2025 and does not utilize...
- The Department of Health and Human Services' National Institutes of Health Clinical Center awarded a $48,209 firm fixed price purchase order to Illumina, Inc. for a service contract to provide a NextSeq 2000 DNA sequencer with serial number VH01190. The single-year contract, valued at forty-eight thousand two hundred nine US dollars, will be performed at the NIH Clinical Center campus located in Bethesda, Maryland through September 2024. Illumina will deliver the requested DNA sequencing...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $516,120.00 firm fixed price purchase order to Illumina, Inc. to procure two NextSeq 550 DNA sequencers. The award does not include any set-aside designation. Illumina, a manufacturer of genomic sequencing and analysis instruments and reagents, has previously provided sequencing systems, reagents, and support services to federal agencies like the NIH, CDC, USDA, and VA...
- <p>The National Institutes of Health National Human Genome Research Institute (NIH NHGRI) awarded a $999,999 firm fixed price purchase order to Illumina, Inc. of San Diego, California for a NOVASEQ X PLUS SEQUENCING SYSTEM. The sequencing system will be delivered to the prime contractor's location in San Diego between June 22, 2023 and September 29, 2023 to support the NIH NHGRI's genomic research efforts.</p>
- The Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations awarded a $290,700 purchase order to Illumina, Inc. of San Diego, California. The firm fixed price contract is to provide an Illumina NextSeq 2000 next-generation sequencer to replace aging equipment at the National Eye Institute. The original solicitation sought to supply the NextSeq 2000 sequencer to reduce reagent costs, eliminate downtime from repairs, and fluidics...
- The U.S. National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), awarded a $11,335.87 firm fixed price delivery order contract to Illumina, Inc., a manufacturer of genetic analysis instruments and reagents. The contract is for the provision of various Illumina sequencing systems, including NextSeq, NovaSeq, MiSeq, and iSeq, along with accompanying consumables, support services, and bioinformatics products. This delivery order award is under a broader...
- This is a firm fixed price purchase order awarded by the National Human Genome Research Institute (NHGRI), which is part of the National Institutes of Health (NIH), a civilian agency. The contract, valued at $770,306.04, was awarded to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract does not have a set-aside designation. Under this contract, Illumina will provide a range of goods and services to support genomic sequencing...
- This firm fixed-price delivery order was awarded by the National Human Genome Research Institute (NHGRI), a civilian agency under the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The $93,534.55 contract is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, sample preparation kits, sequencing chips, support plans, maintenance services, and...